FRANK PERKINS: Open Payments
NPI 1336502921 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 25 payments from 11 companies in 2025. Trend: 2023 $409 · 2024 $564 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $150 |
| Axsome Therapeutics, Inc. | 3 | $137 |
| Lundbeck LLC | 4 | $87 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| ABBVIE INC. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| JAZZ PHARMACEUTICALS INC. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: ARISTADA, Auvelity, ABILIFY ASIMTUFII, VRAYLAR, UZEDY, XYWAV, ABILIFY MAINTENA, SPRAVATO.
Industry payments across MS — which companies pay providers there.
